TrialMe: Difference between revisions
Added new company |
Added valuation: Undisclosed |
||
| Line 11: | Line 11: | ||
== Significance == | == Significance == | ||
Women are historically underrepresented in clinical trials, leading to medications and treatments optimized primarily for male biology. TrialMe's work could improve treatment outcomes for half the population. | Women are historically underrepresented in clinical trials, leading to medications and treatments optimized primarily for male biology. TrialMe's work could improve treatment outcomes for half the population. | ||
== Funding == | |||
'''Valuation:''' Undisclosed | |||
== See Also == | == See Also == | ||
Latest revision as of 07:42, 14 April 2026
What They Do[edit]
Fixing the data gap that keeps women out of clinical trials. TrialMe addresses the historical underrepresentation of women in clinical research by developing tools and methodologies to ensure gender-balanced trial participation.[1]
Significance[edit]
Women are historically underrepresented in clinical trials, leading to medications and treatments optimized primarily for male biology. TrialMe's work could improve treatment outcomes for half the population.
Funding[edit]
Valuation: Undisclosed
See Also[edit]
- ↑ Tech.eu (Dec 18, 2025): "Swedish startup TrialMe is fixing the data gap that keeps women out of clinical trials"